The FAQs relate to the following topics:
- SC1-PM-01-2016: Multi omics for personalised therapies addressing diseases of the immune system ;
- SC1-PM-04-2016: Networking and optimising the use of population cohorts at EU level;
- SC1-PM-09-2016: New therapies for chronic diseases;
- SC1-PM-10-2017: Comparing the effectiveness of existing healthcare interventions in the adult population;
- SC1-PM-21-2016: Implementation research for scaling up of evidence based innovations and good practice in Europe and low- and middle-income countries
They will be of interest to anyone developing applications to these calls.